SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-012594
Filing Date
2022-03-30
Accepted
2022-03-30 16:02:44
Documents
14
Period of Report
2022-03-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acer-8k_20220330.htm   iXBRL 8-K 40586
2 EX-99.1 acer-ex991_15.htm EX-99.1 26789
3 GRAPHIC gsxddw0f2xf0000001.jpg GRAPHIC 17440
  Complete submission text file 0001564590-22-012594.txt   231224

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acer-20220330.xsd EX-101.SCH 5685
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20220330_lab.xml EX-101.LAB 20192
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20220330_pre.xml EX-101.PRE 12031
8 EXTRACTED XBRL INSTANCE DOCUMENT acer-8k_20220330_htm.xml XML 3696
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 22786377
SIC: 2834 Pharmaceutical Preparations